Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD-SW
09618
5
BABA-W
09988
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -7.69%23.64B | -29.29%11.72B | -36.83%5.63B | -8.41%33.74B | 20.71%25.61B | 0.90%16.58B | 5.36%8.91B | -22.51%36.84B | -34.24%21.21B | -35.98%16.43B |
| Refunds of taxes and levies | -16.29%632.78M | -12.67%378.85M | -23.15%117.9M | -5.06%1.06B | -11.46%755.93M | -26.68%433.83M | -31.17%153.43M | -19.60%1.12B | -8.35%853.74M | -5.42%591.69M |
| Net deposit increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in borrowings from central bank | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in placements from other financial institutions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash received from interests, fees and commissions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in repurchase business capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Premiums received from original insurance contracts | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net cash received from reinsurance business | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in deposits from policyholders | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in funds disbursed | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net cash received from trading securities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash received relating to other operating activities | -10.99%1.16B | 27.70%337.91M | 5.23%825.8M | 8.56%2.95B | -66.74%1.3B | -83.93%264.62M | -2.01%784.74M | -23.75%2.72B | -13.90%3.91B | -48.50%1.65B |
| Cash inflows from operating activities | -8.08%25.42B | -28.00%12.44B | -33.26%6.57B | -7.19%37.76B | 6.50%27.66B | -7.46%17.28B | 3.88%9.85B | -22.52%40.68B | -31.15%25.97B | -36.69%18.67B |
| Goods services cash paid | -76.11%1.77B | -78.64%1.17B | -71.93%933.52M | -24.66%8.25B | 1.04%7.39B | 20.14%5.5B | 12.11%3.33B | -14.86%10.95B | -37.95%7.32B | -47.01%4.57B |
| Staff behalf paid | -11.95%2.02B | 1.89%1.53B | -10.64%693.08M | 9.12%4.27B | 12.44%2.29B | 3.91%1.5B | 17.55%775.61M | 5.63%3.91B | 4.14%2.04B | 3.85%1.44B |
| All taxes paid | -1.05%3.52B | 3.46%2.6B | -1.15%1.09B | -4.65%4.39B | -3.36%3.55B | -1.59%2.52B | 0.43%1.1B | 0.43%4.6B | 2.35%3.68B | -2.40%2.56B |
| Net loan and advance increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net deposit in central bank and institutions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net lend capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid for fees and commissions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid for indemnity of original insurance contract | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Policy dividend cash paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid relating to other operating activities | -43.29%2.34B | -2.65%461.02M | 9.64%1.16B | -44.84%3.79B | -40.33%4.12B | -76.95%473.58M | 20.27%1.06B | 291.83%6.87B | 393.10%6.91B | 155.91%2.05B |
| Cash outflows from operating activities | -44.48%9.64B | -42.25%5.77B | -38.09%3.88B | -21.41%20.69B | -12.94%17.37B | -6.06%9.98B | 11.75%6.26B | 15.02%26.33B | 6.40%19.95B | -20.94%10.63B |
| Net cash flows from operating activities | 53.33%15.78B | -8.49%6.67B | -24.84%2.7B | 18.93%17.06B | 70.88%10.29B | -9.31%7.29B | -7.49%3.59B | -51.54%14.35B | -68.25%6.02B | -49.89%8.04B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -75.56%254.83M | -71.68%277.76M | --0 | -31.74%1.62B | 2,382.39%1.04B | 2,235.38%980.86M | 656.67%317.8M | -50.84%2.37B | -97.31%42M | -92.63%42M |
| Cash received from returns on investments | -37.14%41.81M | -25.93%31.09M | -79.08%4.31M | -39.58%115.01M | -41.87%66.5M | -62.09%41.97M | -3.57%20.61M | -69.79%190.36M | -48.21%114.4M | -26.85%110.73M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -31.54%5.58M | 53.65%5.26M | 80.01%422.61K | -40.97%14.08M | -65.46%8.15M | 72.73%3.42M | 1,198.83%234.78K | 27.41%23.85M | 79.04%23.61M | -75.47%1.98M |
| Net cash received from disposal of subsidiaries and other business units | --0 | --0 | --0 | --1.17B | --90.83M | --0 | --0 | --0 | --0 | --0 |
| Cash received relating to other investing activities | --0 | --0 | --0 | --47.78M | --0 | --0 | --0 | --0 | -45.61%1.92B | -49.30%1.74B |
| Cash inflows from investing activities | -74.98%302.21M | -69.39%314.1M | -98.60%4.73M | 14.52%2.96B | -42.50%1.21B | -45.93%1.03B | 434.22%338.64M | -52.75%2.59B | -64.68%2.1B | -60.37%1.9B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 9.33%17.98B | -5.90%12.36B | -24.52%5.16B | 24.00%26.86B | 14.43%16.45B | 17.82%13.13B | 12.05%6.84B | -3.31%21.67B | 44.68%14.38B | 71.59%11.14B |
| Cash paid to acquire investments | -92.03%101.54M | -93.06%79.08M | -87.70%52.88M | -66.72%1.69B | 984.09%1.27B | 14,147.63%1.14B | -79.53%429.8M | 126.86%5.09B | -85.84%117.5M | -90.40%8M |
| Net cash paid to acquire subsidiaries and other business units | --0 | --0 | --0 | --422.6M | -81.16%422.58M | -81.91%390.9M | --268.05M | --0 | 799.12%2.24B | 766.44%2.16B |
| Impawned loan net increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid relating to other investing activities | --0 | --0 | --0 | --49.49M | --0 | 20.14%90M | --0 | --0 | --113.71M | --74.92M |
| Cash outflows from investing activities | -0.33%18.09B | -15.70%12.43B | -30.80%5.22B | 8.50%29.03B | 7.69%18.15B | 10.18%14.75B | -8.13%7.54B | 8.39%26.76B | 52.96%16.85B | 96.10%13.39B |
| Net cash flows from investing activities | -5.00%-17.78B | 11.69%-12.12B | 27.61%-5.21B | -7.86%-26.07B | -14.84%-16.94B | -19.44%-13.72B | 11.57%-7.2B | -25.82%-24.17B | -191.09%-14.75B | -463.69%-11.49B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -91.71%46.25M | -86.02%42.64M | -99.42%549.57K | 163.68%598.19M | 269.41%558.08M | 889.35%304.97M | 5,108.10%95.5M | -75.97%226.86M | -71.88%151.07M | -92.97%30.83M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -91.71%46.25M | -86.02%42.64M | -99.42%549.57K | 163.68%598.19M | 269.41%558.08M | 889.35%304.97M | 5,108.10%95.5M | -75.97%226.86M | -71.88%151.07M | -92.97%30.83M |
| Cash from borrowing | 8.87%145.58B | -1.42%108.78B | 8.26%41.88B | 60.47%247.76B | 14.20%133.72B | 35.93%110.35B | 7.80%38.68B | -8.98%154.39B | -4.98%117.09B | -9.30%81.18B |
| Cash received relating to other financing activities | --89.1M | -61.51%89.1M | --0 | --0 | --0 | 112.93%231.48M | --0 | --784.84M | --108.71M | --108.71M |
| Cash inflows from financing activities | 8.51%145.71B | -1.78%108.92B | 8.00%41.88B | 59.81%248.36B | 14.42%134.28B | 36.35%110.88B | 8.06%38.78B | -8.89%155.4B | -5.18%117.35B | -9.59%81.32B |
| Borrowing repayment | 15.54%140.26B | -1.06%102.6B | 8.92%38.46B | 53.49%230.31B | 9.11%121.4B | 35.80%103.7B | 9.66%35.32B | -2.47%150.04B | -5.29%111.27B | -10.55%76.36B |
| Dividend interest payment | 0.82%4.77B | 11.65%1.84B | 19.58%978.33M | 11.54%6.25B | 52.01%4.73B | -15.13%1.65B | -10.13%818.14M | 7.85%5.61B | -30.58%3.11B | 4.09%1.95B |
| -Including:Cash payments for dividends or profit to minority shareholders | -11.08%384.11M | -43.59%83.49M | -0.30%63.23M | 4.02%746.86M | 36.88%431.95M | -12.30%148.02M | -20.82%63.42M | 65.89%717.97M | 962.54%315.58M | 468.28%168.78M |
| Cash payments relating to other financing activities | -92.09%216.18M | -76.96%145.06M | -79.40%40.52M | 23.34%4.44B | -18.26%2.73B | 218.28%629.64M | 5,320.56%196.76M | -51.89%3.6B | -43.26%3.34B | -96.60%197.83M |
| Cash outflows from financing activities | 12.72%145.24B | -1.32%104.59B | 8.68%39.48B | 51.34%241.01B | 9.46%128.86B | 35.00%105.98B | 9.69%36.33B | -4.37%159.25B | -7.92%117.72B | -15.64%78.5B |
| Net cash flows from financing activities | -91.38%467.06M | -11.71%4.33B | -2.13%2.39B | 291.09%7.35B | 1,570.35%5.42B | 74.11%4.9B | -11.53%2.45B | -195.21%-3.85B | 90.98%-368.53M | 190.39%2.82B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -62.49%-28.75M | 135.68%9.36M | 315.41%8.65M | -728.64%-32.5M | 44.75%-17.69M | -49.18%-26.23M | -128.70%-4.01M | 146.48%5.17M | -203.95%-32.03M | -190.25%-17.59M |
| Net increase in cash and cash equivalents | -25.71%-1.56B | 28.69%-1.11B | 90.37%-112.68M | 87.66%-1.69B | 86.39%-1.24B | -139.17%-1.56B | 21.21%-1.17B | -194.73%-13.67B | -192.59%-9.12B | -105.96%-650.35M |
| Add:Begin period cash and cash equivalents | -35.09%3.13B | -35.09%3.13B | -35.05%3.12B | -73.96%4.81B | -73.72%4.83B | -73.72%4.83B | -73.81%4.81B | 372.16%18.48B | 369.33%18.37B | 369.33%18.37B |
| End period cash equivalent | -56.16%1.57B | -38.13%2.02B | -17.26%3.01B | -35.05%3.12B | -61.21%3.58B | -81.54%3.27B | -78.43%3.64B | -73.77%4.81B | -32.89%9.24B | 19.49%17.72B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.